Skip to content

Clinical trials

Completed Hypercholesterolemia trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Status: Completed Country / region: Canada Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20053
20064
20073
20085
20097
20102
201110
201215
201316
20142
20153
20169
20172
20183
20194
20201
20223
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed102

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen22
Sanofi10
Regeneron Pharmaceuticals7
University of Manitoba7
University of Toronto5
Kastle Therapeutics, LLC4
Esperion Therapeutics, Inc.3
Takeda3
Laval University2
Merck Sharp & Dohme LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia102
Hyperlipidemias21
Cardiovascular Diseases13
Hyperlipoproteinemia Type II12
Dyslipidemias9
Homozygous Familial Hypercholesterolemia8
Diabetes Mellitus6
Coronary Disease5
Hypertension5
Atherosclerosis4

Trials

Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.